14 Severe gastrointestinal issues Patients with severe gastrointestinal issues - inflammatory bowel disease, gastroparesis, history of gastrointestinal surgery
Offering retatrutide on a patient-by-patient basis instead of opening a program for an intermediate or large group of patients is inherently narrowing, Bateman-House said
If a patients expectation is that a weekly injection will produce weight loss without dietary change, the ethical move is to reset the expectation or decline the treatment not to sell the package
Avoid the Fat Burner and Day Burner, which contain caffeine, especially later in the day
drug developers and producers
A 2021 review of NNMT as a metabolic target stated plainly that clinical trials targeting NNMT have not been reported until now (Liu 2021, PMID 34368359) [5], and that held into 2026